A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6).
| Autor: | Olander, Kenneth W., Sato, Michelle A., Abrams, Marc A., Jerkins, Gary W., Fenghe Lu, Dinh, Phillip, Odani-Kawabata, Noriko, Chabi, Almira, Shams, Naveed K. |
|---|---|
| Zdroj: | Journal of Glaucoma; Jun2021, Vol. 30 Issue 6, p473-480, 8p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|